Výsledky vyhledávání - X. Cynthia
- Zobrazuji výsledky 1 - 20 z 76
- Přejít na další stránku
-
1
Letrozole in the neoadjuvant setting: the P024 trial Autor Matthew J. Ellis, X. Cynthia
Vydáno 2007Artigo -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Resp... Autor Carla S. Fisher, X. Cynthia, William E. Gillanders, Rebecca Aft, Timothy J. Eberlein, Feng Gao, Julie A. Margenthaler
Vydáno 2011Artigo -
16
Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer Autor César Sánchez, X. Cynthia, Robert J. Crowder, Therese Guintoli, Chanpheng Phommaly, Feng Gao, Lin Li, Matthew J. Ellis
Vydáno 2011Artigo -
17
Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells Autor Venkataswarup Tiriveedhi, Timothy P. Fleming, Peter S. Goedegebuure, Michael Naughton, X. Cynthia, Craig Lockhart, Feng Gao, William E. Gillanders, T. Mohanakumar
Vydáno 2012Artigo -
18
-
19
Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma Autor X. Cynthia, Martha Q. Lacy, John F. Rompala, Angela Dispenzieri, S. Vincent Rajkumar, Philip R. Greipp, Rafaël Fonseca, Robert A. Kyle, Morie A. Gertz
Vydáno 2004Artigo -
20
Endocrine Therapy With or Without Inhibition of Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2: A Randomized, Double-Blind, Placebo-Controlled Phase... Autor Harold J. Burstein, Constance Cirrincione, William T. Barry, Helen K. Chew, Sara M. Tolaney, Diana Lake, X. Cynthia, Kimberly Blackwell, Eric P. Winer, Clifford A. Hudis
Vydáno 2014Artigo
Vyhledávací nástroje:
Související témata
Cancer
Medicine
Internal medicine
Breast cancer
Oncology
Biology
Cancer research
Metastatic breast cancer
Estrogen receptor
Chemotherapy
Genetics
Biochemistry
Gene
Fulvestrant
Tamoxifen
Triple-negative breast cancer
Cell cycle
Immunology
Trastuzumab
Clinical trial
Confidence interval
Hazard ratio
Palbociclib
Anastrozole
Clinical endpoint
Gastroenterology
Aromatase inhibitor
Cell biology
Gynecology
Immune system